首页> 中文期刊> 《当代医学》 >腹腔镜保留脾、胰尾肿瘤切除术的安全性及可行性分析

腹腔镜保留脾、胰尾肿瘤切除术的安全性及可行性分析

         

摘要

Objective To explore the safety and feasibility of the laparoscopic pancreas tail tumor resection reserved spleen. Methods 50 cases of patients who had pancreatic tail tumor by the clinical diagnosis and had been treated in our hospital from July, 2010 to July, 2012 were selected. They were treated with laparoscopic pancreas tail tumor resection reserved spleen, and the safety and feasibility were analyzed. Results The rates of successfully completed surgery and complication of patients in the observation group were 100% and 0%, and those of patients in the control group were 60% and 32%. The rate of successfully completed surgery of patients in the observation group was signifcantly higher and the rate of complication was signifcantly lower than those of patients in the control group, the difference was statistically signifcant (P<0.05); However, the difference of duration healed was not statistically signifcant (P>0.05). Conclusion Laparoscopic pancreas tail tumor resection reserved spleen is feasible to resected the isolated pancreas tail tumor, concentrates the advantages of traditional surgery’s security and laparoscopic surgery’s minimally invasive, it is worthy of promotion.%  目的探究腹腔镜保留脾、胰尾肿瘤切除术的安全性及可行性。方法选取广东茂名石化医院2010年7月-2012年7月收治的50例临床诊断为胰尾肿瘤患者,对其行腹腔镜保留脾脏肿瘤切除术,然后分析其安全性及可行性。结果观察组患者顺利完成手术率和并发症发生率分别为100%和0,对照组患者顺利完成手术率和并发症发生率分别为60%和32%,观察组患者顺利完成手术率明显比对照组高,并发症发生率明显比对照组低,二者差异具有统计学意义(P﹤0.05);但在痊愈时长方面二者差异不具有统计学意义(P>0.05)。结论腹腔镜保留脾、胰尾肿瘤切除术在切除胰尾孤立肿瘤方面是可行的,具有传统手术的安全性和腹腔镜手术的微创性,值得临床推广。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号